Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I really think we will see volume subside for a period if no news followed by a couple days of higher volume with little movement than we will surge. If you see the volume preceding the price move all in. This should run hard.
Understandable after these last few days.
Better than the -11% we hit earlier.
Why the added dialogue today? Wonder if something has finished or changed.
Be careful putting sell points on a MB. MMs will use anything to make cash.
Vomit in my mouth.
I think we started this process in June. IMO we are looking at some time in August at the latest.
My last post after a tough day, but thank you Dr. Bob. Your expertise is invaluable. Every time you show up I believe it steadies retail investors.
Lasers can you post short numbers from last few days?
Right. Which reacts like dilution because more shares are floated than exist.
I posted this whole thing earlier with the link, but really look at it. Bashers out in force, extremely high volume, followed by long time posters turning. THIS IS MANIPULATION. Shorts WILL have to cover. There is no way we sold off on this much volume after positive results at ASCO and 8% dilution. Get rid of the emotions and bring logic back into it. I have no clue about any news. But we will run due to short covering and sellers remorse turned to chasing. Buy up what you can now and reassess as we move through resistance zones on the way up. Making money is NEVER easy.
Stage 6: Pressure
The shorts have taken it too far. The volume is increasing and the price is not effectively dropping. A stalemate occurs. Personal attacks increase. Threats of legal action, SEC involvement, and yes even death threats increase. Increased secret IDs are employed to increase the cluttering, personal attacks and the distortion. So begins a string of lies that run for as long as one's stomach can take it. Desperately playing on the "you have been had" scenario. Any new news will be hit it hard by shorters to kill any interest.
Note: Watch the volume not the share price. A market manipulator will have various brokers buying and selling the stock to give the APPEARANCE of increasing volume but the price goes down. Thus stimulating the story the company is selling or an off shore reg S or other convenient scenario. Watch for large blocks that show up but have a MM special code, cross overs, etc. In our case an s-3
This is a no news price drop in a micro cap biotech right after good news. Time to put on big boy pants and make some money. Your post have been on point.
STAGES FOR THE DEADLY ART OF STOCK MANIPULATION
The Short & Distort Scheme
Stage I: Monitoring
In stage I of a Short & Distort scheme Short groups Monitor spikes in volumes on stocks with no rumors.
Stage 2: Flagging
Shorts Flag stocks that run up then sits back and wait patiently for their time.
Stage 3: Preparation
The Shorters research the company and develop their Distortion of the rumors to be used later.
Stage 4: Actual Shorting
The shorts step in selling on every possible up tick. This is the Reverse of front loading. Preparations are made to attack the guy who had earlier written positively about the company and take out, discredit, any new long-term champions or messengers.
Stage 5: Distortion Campaign
The shorts step in and increase selling on every possible up tick. Just as with the pump, newsletters, e-mail, PR firms against P & D, etc. are simulated. Expertise in the field is recruited for credibility. Any possible twist using POS (Purposely Omitted Syntax) and PAS (Purposely Added Syntax) is conveniently used on every possible angle. If the POS/PAS is discovered then attack the messenger. Above all control the message boards.
The group clutters the message boards so no positive information can be readily found. Justification is the Value of the Company in the market. Projections of $0.00 worth and loss projections of 100%
Note: The market manipulator will do everything in his/her power to keep buyers OUT OF THE STOCK. Cut your losses is touted to stimulate fear. You bought higher but now they need you to sell lower.
Stage 6: Pressure
The shorts have taken it too far. The volume is increasing and the price is not effectively dropping. A stalemate occurs. Personal attacks increase. Threats of legal action, SEC involvement, and yes even death threats increase. Increased secret IDs are employed to increase the cluttering, personal attacks and the distortion. So begins a string of lies that run for as long as one's stomach can take it. Desperately playing on the "you have been had" scenario. Any new news will be hit it hard by shorters to kill any interest.
Note: Watch the volume not the share price. A market manipulator will have various brokers buying and selling the stock to give the APPEARANCE of increasing volume but the price goes down. Thus stimulating the story the company is selling or an off shore reg S or other convenient scenario. Watch for large blocks that show up but have a MM special code, cross overs, etc.
Stage 7: The Cover
Without warning the buying pressure is too much and the short begins to cover. Short covering combined with new investors buying into the stock causes the stock to go up. Often the whole thing starts again. Just a vicious cycle sometimes.
I don't think retail is selling this high volume. That leads me to shorts that will have to cover at some point. The more short volume the more violent the pop will be when this reverses.
A bit oversold wouldn't you say?
Just grabbed some more shares. I'm swimming in ONCS now. I figure worst case scenario we get a bounce. This was too far too fast. Any idea on what RSI is sitting at?
I have but it has always been after a big run up. We based in the .7s for a month, and started the run up there before we knew if ONCS was going to present ASCO. So I dont think it is a post ASCO unloading. I'm dumbfounded right now, and pretty sure an MM just took my shirt through the computer screen.
Your call is looking pretty accurate right now. This seems determined to hit that support before any reversal.
He is not posting anything false. Just links from DD that he is doing. Do not scare away everyone not pumping. Let people post balanced info. It helps us all.
Interesting article, but I am hoping ASCO as well as these other major biotech conferences have done their research before featuring ONCS.
The market will be fine until interest rates rise. There is no fixed income or foreign markets worth much. With a lack of options the globe tends to turn to US equities. We should have some time before anything big, but its never a bad idea to go defensive in your portfolio after a few year run up. Or if you know what you are doing buy some put options so you don't lose a chance at a sustained bull market but protect yourself against downside risk. It won't matter though because we will all be rich when ONCS changes cancer therapy.
I agree. I've been in other companies this size and they usually get up for these meetings. They know they will need capital at some point because revenue is still a few years away. They are so quite, which is really out of character, and avoiding the potential for any questions at the shareholder meeting. It looks like a confidentiality agreement is in place, and we won't hear why until sometime after the meeting.
I see 4 reasons for that:
1. An agreement from the private placement
2. A pending agreement for the rest of the S-3
3. Partnership negotiations
4. FDA requiring it, but I have never seen that.
I guess as JJ will point out, its just speculation at this point.
Does it seem odd to you to have no shareholders present at a shareholder meeting?
I did the same than bought again at .6. This is really no fun but the volume of selling is HUGE. Has to be a massive shareholder that got fed up or a coordinated effort. The is too heavily owned by retail for all the shareholders to bail on one day.
It seems they are trying to keep this meeting very low key. So my inclination is to say no, but I am not sure. I am out of my office today, but if you e-mail IR they will let you know and give you a link if there is one.
(4) to transact other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
At least that leaves hope for something fun to vote for.
Pps aside I think shareholder meetings should be something management gets excited about and tries to have a good turnout for. They seem to be trying to keep this one low key.
That's no excuse. Updating the website with pertinent information is essential. Especially a shareholder meeting after an unexplained dilution and price drop. I'm here because immunopulse could be a game changer, but management should respect investors or they will have trouble raising capital in the future.
I would not call that peanuts for a prerevenue company. He defiantly has a vested interest in the share price though.
Really not what I was looking for on Monday morning.
I hope so too. They were always very forthcoming with information. Even leading up to ASCO, which has very strict rules. Hopefully they are in negotiations and can not comment until it is finalized. If it's not that I can only guess that the S-3 after ASCO was a bad decision and Punit is embarrassed about it.
Punit even said after the dilution that he was excited to let shareholders know who it was. That was the last he spoke of it.
Go to the post and click public reply
A lot of volatility this morning.
Good find. Didn't H.C. Wainwright help with the private placement for ONCS?
Unless you are talking about cash payments to use oncs's patents, but I'm not sure that would be a great deal. If this is really able to turn non-responders into responders I wouldn't want a long term rights deal until this is further along. The potential is to big.
Wouldn't that need multiple trials for each PD-1 tested? It would be great to see them run more than one, and would spread a lot of the risk out but that would be pretty expensive.
I was reading through current filings and saw Punit owned some but it looked like it was what he kept during inception. I couldn't find much else. I like when startup biotechs pay part of compensation in shares so goals are aligned. It would take some of the steam out of the offering conspiracy theory that the institution sold short and used the offering to cover. If management was being paid in shares there would be less doubt of vetting the institution and more motivation to use the S-3 in another way. It helps maintain confidence during rough patches.